A detailed history of Front Row Advisors LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Front Row Advisors LLC holds 100 shares of TNDM stock, worth $3,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 288 65.28%
Holding current value
$3,590
Previous $11,000 63.64%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$35.21 - $47.3 $6,619 - $8,892
-188 Reduced 65.28%
100 $4,000
Q2 2024

Aug 15, 2024

SELL
$30.43 - $53.43 $821 - $1,442
-27 Reduced 8.57%
288 $11,000
Q1 2024

May 14, 2024

BUY
$22.09 - $35.41 $4,749 - $7,613
215 Added 215.0%
315 $11,000
Q1 2023

May 22, 2023

BUY
$35.86 - $46.5 $3,442 - $4,464
96 Added 2400.0%
100 $4,000
Q1 2023

May 15, 2023

SELL
$35.86 - $46.5 $3,442 - $4,464
-96 Reduced 96.0%
4 $10,000
Q3 2018

Nov 13, 2018

BUY
$21.39 - $51.17 $2,139 - $5,117
100 New
100 $3,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.31B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.